1612 related articles for article (PubMed ID: 16651866)
1. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.
Von dem Borne PA; Bajzar L; Meijers JC; Nesheim ME; Bouma BN
J Clin Invest; 1997 May; 99(10):2323-7. PubMed ID: 9153272
[TBL] [Abstract][Full Text] [Related]
3. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
[TBL] [Abstract][Full Text] [Related]
4. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.
von dem Borne PA; Meijers JC; Bouma BN
Blood; 1995 Oct; 86(8):3035-42. PubMed ID: 7579397
[TBL] [Abstract][Full Text] [Related]
5. Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation.
Bouma BN; Mosnier LO; Meijers JC; Griffin JH
Thromb Haemost; 1999 Dec; 82(6):1703-8. PubMed ID: 10613658
[TBL] [Abstract][Full Text] [Related]
6. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
[TBL] [Abstract][Full Text] [Related]
7. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
Torbet J
Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
[TBL] [Abstract][Full Text] [Related]
8. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
von dem Borne PA; Meijers JC; Bouma BN
Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
[TBL] [Abstract][Full Text] [Related]
9. Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation.
Nielsen VG
Ann Thorac Surg; 2006 May; 81(5):1720-7. PubMed ID: 16631662
[TBL] [Abstract][Full Text] [Related]
10. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional roles of thrombin.
Narayanan S
Ann Clin Lab Sci; 1999; 29(4):275-80. PubMed ID: 10528826
[TBL] [Abstract][Full Text] [Related]
12. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available.
Wielders SJ; Béguin S; Hemker HC; Lindhout T
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1138-42. PubMed ID: 15072993
[TBL] [Abstract][Full Text] [Related]
13. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
14. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
Guimarães AH; Rijken DC
Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
[TBL] [Abstract][Full Text] [Related]
15. The role of factor XI in coagulation: a matter of revision.
Minnema MC; Ten Cate H; Hack CE
Semin Thromb Hemost; 1999; 25(4):419-28. PubMed ID: 10548074
[TBL] [Abstract][Full Text] [Related]
16. Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin.
Colucci M; Pentimone A; Binetti BM; Cramarossa M; Piro D; Semeraro N
Thromb Haemost; 2002 Aug; 88(2):282-7. PubMed ID: 12195701
[TBL] [Abstract][Full Text] [Related]
17. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
[TBL] [Abstract][Full Text] [Related]
18. High dose factor VIIa improves clot structure and stability in a model of haemophilia B.
Wolberg AS; Allen GA; Monroe DM; Hedner U; Roberts HR; Hoffman M
Br J Haematol; 2005 Dec; 131(5):645-55. PubMed ID: 16351642
[TBL] [Abstract][Full Text] [Related]
19. Role of blood coagulation factor XI in downregulation of fibrinolysis.
Bouma BN; Meijers JC
Curr Opin Hematol; 2000 Sep; 7(5):266-72. PubMed ID: 10961575
[TBL] [Abstract][Full Text] [Related]
20. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
